MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,007,000 | -3.3% | 108,894 | +1.7% | 0.05% | -2.0% |
| Q4 2015 | $5,179,000 | -19.5% | 107,118 | -29.2% | 0.05% | -38.0% |
| Q3 2015 | $6,430,000 | -76.5% | 151,296 | -37.0% | 0.08% | -77.9% |
| Q2 2015 | $27,417,000 | -41.1% | 240,080 | -33.4% | 0.36% | -41.0% |
| Q1 2015 | $46,551,000 | +5.4% | 360,669 | -18.7% | 0.61% | +4.1% |
| Q4 2014 | $44,172,000 | +1131.1% | 443,456 | +1121.9% | 0.58% | +1021.2% |
| Q3 2014 | $3,588,000 | -56.7% | 36,293 | -66.2% | 0.05% | -57.4% |
| Q2 2014 | $8,278,000 | +879.6% | 107,395 | +718.6% | 0.12% | +713.3% |
| Q1 2014 | $845,000 | – | 13,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |